Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2022 Annual Meeting | C3 - Treatment of Pediatric Multiple Sclerosis in the Current Era

Saturday 04/02/22
07:00 AM - 09:00 AM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Brenda Banwell, MD, FAAN
Multiple Sclerosis, Child Neurology and Developmental Neurology
The Pediatric Multiple Sclerosis Therapy course will address the following: increase attendee knowledge regarding the approach to the diagnosis of Pediatric MS including considerations of MOG testing, will summarize current literature regarding treatments for acute relapses and for disease modulation and will address the impact of pediatric MS on cognitive function and academics and strategies for rehabilitation.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Advanced
Fellow, Resident, General Neurologist, Specialist Neurologist, Medical Student
Didactic

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:05 AM PDT Introduction Welcome and Introduction
Brenda Banwell, MD, FAAN
07:00 AM - 09:00 AM PDT Speaker walk in slides
Brenda Banwell, MD, FAAN
07:05 AM - 07:40 AM PDT Speaker Diagnosis of Pediatric MS Including Considerations of MOG Testing
Brenda Banwell, MD, FAAN
07:40 AM - 08:15 AM PDT Speaker Current Therapies and the Emerging Treatment Landscape
Jennifer Graves, MD, PhD
08:15 AM - 08:50 AM PDT Speaker Impact of Pediatric MS on Cognitive Function and Academics and Strategies for Rehabilitation
Wendy Sulina Vargas, MD
08:50 AM - 09:00 AM PDT Q&A Questions and Answers
Brenda Banwell, MD, FAAN, Jennifer Graves, MD, PhD, Wendy Sulina Vargas, MD
Faculty Disclosures
Brenda Banwell, MD, FAAN Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
Jennifer Graves, MD, PhD Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Graves has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MSJ. The institution of Dr. Graves has received research support from Octave. The institution of Dr. Graves has received research support from Sanofi. The institution of Dr. Graves has received research support from EMD Serono.
Wendy Sulina Vargas, MD Dr. Vargas has received personal compensation for serving as an employee of Sanofi. The institution of Dr. Vargas has received research support from NICHD.